Shortage reports
Actual shortage:
259 (8%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3057 (92%)
3327
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
28 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Actual shortage | 2026-03-12 | 2026-04-09 | 280410 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2022-04-21 | 2022-08-19 | 159213 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108009 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108003 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108006 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108012 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1664 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1659 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2023-07-11 | 2023-12-14 | 198283 |
| TEVA-TRAZODONE | 150MG | TABLET | Actual shortage | 2026-02-26 | 2026-04-02 | 279097 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-05-12 | 2023-07-06 | 160457 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-07-18 | 2023-10-06 | 199015 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-06-19 | 2023-06-27 | 195624 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-06-19 | 2023-06-27 | 195637 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-05-19 | 2023-07-06 | 161009 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2022-06-30 | 2023-06-27 | 163921 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2019-10-31 | 2019-11-08 | 97599 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2023-07-11 | 2023-12-14 | 198280 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2026-01-22 | 2026-03-24 | 276485 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-07-27 | 2023-10-06 | 200223 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN | 375MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258493 |
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258436 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |